A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease

A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease

<p>Abstract</p> <p>Background</p> <p>Non-alcoholic fatty liver disease (NAFLD) has a prevalence of over 20% in Western societies. Affected individuals are at risk of developing both cirrhosis and hepatocellular cancer (HCC). Presently there is no cost effective populati...

Full description

Bibliographic Details
Main Authors: Stewart Stephen, King Barry P, Miele Luca, Patman Gillian L, Beale Gary S, Chattopadhyay Dipankar, Gray Joe, Hudson Mark, Day Christopher P, Manas Derek M, Reeves Helen L
Format: Article
Language:English
Published: BMC 2009-08-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/9/271

Internet

http://www.biomedcentral.com/1471-2407/9/271

Similar Items